» Articles » PMID: 29600553

A Multiple Mediator Analysis Approach to Quantify the Effects of the ADH1B and ALDH2 Genes on Hepatocellular Carcinoma Risk

Overview
Journal Genet Epidemiol
Specialties Genetics
Public Health
Date 2018 Mar 31
PMID 29600553
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Previous work suggested a genetic component affecting the risk of hepatocellular carcinoma (HCC) and mediation analyses have elucidated potential indirect pathways of these genetic effects. Specifically, the effects of alcohol dehydrogenase (ADH1B) and aldehyde dehydrogenase (ALDH2) genes on HCC risk vary based on alcohol consumption habits. However, alcohol consumption may not be the only mediator in the identified pathway: factors related to alcohol consumption may contribute to the same indirect pathway. Thus, we developed a multimediator model to quantify the genetic effects on HCC risk through sequential dichotomous mediators under the counterfactual framework. Our method provided a closed form formula for the mediation effects through different indirect paths, which requires no assumption for the rarity of outcome. In simulation studies of a finite sample, we presented the utility of the method with the variance of the effects estimated using the delta method and bootstrapping. We applied our method to data from participants in Taiwan (580 cases and 3,207 controls) and quantified the mediation effects of single nucleotide polymorphisms (SNPs) in the ADH1B and ALDH2 genes on HCC through alcohol consumption (yes/no) and high alanine transaminase (ALT) levels (greater than or equal to 45 U/L or below 45 U/L). Assuming a dominant risk model, we identified that the SNPs' effects through alcohol consumption is more significant than through ALT levels on HCC risk. This new method provides insight to the magnitude of various casual mechanisms as a closed form solution and can be readily applied in other genomic studies.

Citing Articles

Bioinformatics combined with network pharmacology and experimental validation to identify key biomarkers of hepatocellular carcinoma and corresponding compounds in Radix Astragali and Pueraria Mirifica.

Li M, Liu B, Xian M, Wang S, Liu P Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39549064 DOI: 10.1007/s00210-024-03597-4.


Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.

Yin D, Zhang Y, Li H, Cheng L Clin Respir J. 2023; 17(12):1301-1315.

PMID: 37985446 PMC: 10730466. DOI: 10.1111/crj.13717.


Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma.

Long G, Wang D, Tang J, Tang W Aging (Albany NY). 2023; 15(15):7593-7615.

PMID: 37540213 PMC: 10457071. DOI: 10.18632/aging.204928.


Why does mode of conception affect early breastfeeding outcomes? A retrospective cohort study.

Weng S, Chien L, Huang Y, Huang Y, Chang M PLoS One. 2022; 17(3):e0265776.

PMID: 35303044 PMC: 8932581. DOI: 10.1371/journal.pone.0265776.


Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH).

Hsieh H, Su J, Wang S, Huang Y BMC Pregnancy Childbirth. 2020; 20(1):209.

PMID: 32272911 PMC: 7147042. DOI: 10.1186/s12884-020-02875-2.


References
1.
Kim W, Flamm S, Di Bisceglie A, Bodenheimer H . Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008; 47(4):1363-70. DOI: 10.1002/hep.22109. View

2.
Seitz H, Stickel F . Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006; 387(4):349-60. DOI: 10.1515/BC.2006.047. View

3.
Lange T, Hansen J . Direct and indirect effects in a survival context. Epidemiology. 2011; 22(4):575-81. DOI: 10.1097/EDE.0b013e31821c680c. View

4.
Wang J, Spitz M, Amos C, Wu X, Wetter D, Cinciripini P . Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One. 2012; 7(10):e47705. PMC: 3471886. DOI: 10.1371/journal.pone.0047705. View

5.
Zhu R, Seto W, Lai C, Yuen M . Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver. 2016; 10(3):332-9. PMC: 4849684. DOI: 10.5009/gnl15257. View